Linked Life Data

11855142

Source:http://linkedlifedata.com/resource/pubmed/id/11855142

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2002-2-21
pubmed:abstractText
Two kinds of murine interleukin-12 (mIL-12) fusion gene vaccines were used to treat the murine low-load malignant T cell lymphoma EL4 as minimal residual disease (MRD) model.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0253-2727
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
565-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
[Experimental study of interleukin-12 gene vaccines in the treatment of low-load malignant lymphoma (EL4)].
pubmed:affiliation
Department of Hematology, Lanzhou General Hospital, Lanzhou 730050, China.
pubmed:publicationType
Journal Article, English Abstract